2023 annual financial data
Cytek Biosciences 2023 Operating margin
Cytek Biosciences 2023 operating margin with verified reported values.
Direct answer
Operating margin was -14.43%.
Operating income was -27,845,000 USD and net income was -12,148,000 USD.
Operating cash flow was 5,281,000 USD.
Get free Cytek Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 193,015,000 USD
- Operating income
- -27,845,000 USD
- Net income
- -12,148,000 USD
- Operating cash flow
- 5,281,000 USD